Publicly Listed MEI Pharma Completes $100.00M Private Placement, to be Used for Litecoin Strategic Reserve

MEI Pharma Announces Completion of $100 Million Private Placement, Selling 29,239,767 Shares of Common Stock or Equivalent Pre-Funded Warrants at $3.42 per Share, Proceeds to be Used to Establish Litecoin Strategic Reserve. The company also appointed Litecoin founder and lead investor in the private placement, Charlie Lee, to the board of directors, and designated GSR as its digital asset and fund management advisor, responsible for overseeing the implementation of the Litecoin reserve strategy. (businesswire) [Odaily]